Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets
about
Sirtuin functions and modulation: from chemistry to the clinicEpigenetics in Schistosomes: What We Know and What We Need KnowEpigenetic changes modulate schistosome egg formation and are a novel target for reducing transmission of schistosomiasisFast evolutionary rates associated with functional loss in class I glucose transporters of Schistosoma mansoniCombattre les maladies négligées en ciblant sélectivement leurs enzymes épigénétiques : le cas de la désacétylase 8 (HDAC8) de Schistosoma mansoni.Histone deacetylase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene transcription in Schistosoma mansoniElucidating the molecular bases of epigenetic inheritance in non-model invertebrates: the case of the root-knot nematode Meloidogyne incognita.Epigenetic control of gene function in schistosomes: a source of therapeutic targets?In-silico screening of Schistosoma mansoni Sirtuin1 inhibitors for prioritization of drug candidatesAnaplasma phagocytophilum increases the levels of histone modifying enzymes to inhibit cell apoptosis and facilitate pathogen infection in the tick vector Ixodes scapularis.Parishin from Gastrodia elata Extends the Lifespan of Yeast via Regulation of Sir2/Uth1/TOR Signaling PathwayMolecular characterization and protective efficacy of silent information regulator 2A from Eimeria tenella.Epigenetic drug discovery for Alzheimer's disease.Natural products as leads in schistosome drug discovery.Schistosome sirtuins as drug targets.Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives.Seeding for sirtuins: microseed matrix seeding to obtain crystals of human Sirt3 and Sirt2 suitable for soaking.Recent advances in proteomic applications for schistosomiasis research: potential clinical impact.The Current State of NAD(+) -Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets.Fluorescence-based screening assays for the NAD⁺-dependent histone deacetylase smSirt2 from Schistosoma mansoni.Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni.How has the genomics era impacted schistosomiasis drug discovery?In-silico analysis of Sirt2 from Schistosoma mansoni: structures, conformations, and interactions with inhibitors.
P2860
Q26745884-A53EAD6B-3CE9-4BB1-9339-1BE848AE6EB5Q28076986-D06259E0-3C7B-41E9-B845-41B6DCEAEF32Q28538592-85AA83A5-DDAD-4524-8D1C-80F5AC897580Q28607183-66F66C08-3155-4174-8C43-CB23ABC85FC6Q30315847-94906B49-749A-4E22-B5AF-ABE3A7F9DB78Q33602816-F2A5C96A-5793-4B3C-9013-36D996BE2CCBQ33720010-A78EB898-4271-4879-A1E2-AF5CDDDC6E06Q34159188-94374685-6FEA-46E3-AC5A-2F27645AFCDEQ36660891-4771723F-01BC-4690-89BD-38CB6018B112Q36956991-FADA54A6-1794-40B9-BE78-FD7AF5836621Q37081076-B4625540-FA63-4BE7-9C7C-95E941538063Q37440560-F53F49EB-FB23-47AC-881B-C54BF02A0060Q38225708-38A3EAFE-0ABE-4835-B878-4A75C7FFDC99Q38334179-08C9C5AE-512F-453D-AC01-97C0AE3A79B3Q38495049-76189855-D0F8-42F1-AA93-3AACF6C18C3FQ38495057-280C7789-9CCD-49BC-93A5-9A585883953CQ38936741-7E5D6E43-F9FD-400F-896A-CE7C4BE6643CQ39034549-312F4ABA-112A-4F21-B4F0-30A1E168A674Q39091771-26CD7ACB-6B6E-4818-922F-65C2AF12A16CQ41697166-0D65CE79-94B4-4593-A65B-A5FAB77F76E9Q48237579-96FD3047-5B2D-4D1F-A09D-4A957207B123Q48478663-2FC9C28A-D812-4379-BF94-3F40EAB22E14Q50893356-A0332203-B04F-41A4-9B65-F08619BC14B9
P2860
Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets
@ast
Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets
@en
Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets
@nl
type
label
Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets
@ast
Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets
@en
Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets
@nl
prefLabel
Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets
@ast
Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets
@en
Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets
@nl
P2093
P2860
P50
P921
P3181
P1476
Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets
@en
P2093
Florence Dubois-Abdesselem
Franz Bracher
Jacques Trolet
Julien Lancelot
Mathieu Vanderstraete
Raymond J Pierce
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0002428
P407
P577
2013-09-12T00:00:00Z